Multiple Assemblies exist for SMTL entry 1ncq
The structure of HRV14 when complexed with pleconaril, an antiviral compound; X-RAY DIFFRACTION 2.50 Å

SMTL ID
1ncq.1
Ligands
3-{3,5-DIMETHYL-4-[3-(3-METHYL-ISOXAZOL-5-YL)-PROPOXY]-PHENYL}-5-TRIFLUOROMETHYL-[1,2,4]OXADIAZOLE
Polypeptides
COAT PROTEIN VP1; COAT PROTEIN VP2; COAT PROTEIN VP3; COAT PROTEIN VP4
Oligo-state
hetero-oligomer
SMTL ID
1ncq.2
Ligands
3-{3,5-DIMETHYL-4-[3-(3-METHYL-ISOXAZOL-5-YL)-PROPOXY]-PHENYL}-5-TRIFLUOROMETHYL-[1,2,4]OXADIAZOLE
Polypeptides
COAT PROTEIN VP1; COAT PROTEIN VP2; COAT PROTEIN VP3; COAT PROTEIN VP4
Oligo-state
hetero-oligomer
SMTL ID
1ncq.3
Ligands
3-{3,5-DIMETHYL-4-[3-(3-METHYL-ISOXAZOL-5-YL)-PROPOXY]-PHENYL}-5-TRIFLUOROMETHYL-[1,2,4]OXADIAZOLE
Polypeptides
COAT PROTEIN VP1; COAT PROTEIN VP2; COAT PROTEIN VP3; COAT PROTEIN VP4
Oligo-state
hetero-oligomer
SMTL ID
1ncq.4
Ligands
3-{3,5-DIMETHYL-4-[3-(3-METHYL-ISOXAZOL-5-YL)-PROPOXY]-PHENYL}-5-TRIFLUOROMETHYL-[1,2,4]OXADIAZOLE
Polypeptides
COAT PROTEIN VP1; COAT PROTEIN VP2; COAT PROTEIN VP3; COAT PROTEIN VP4
Oligo-state
hetero-oligomer